⌘K

Login Start Free

Home/Filings/4/0001178913-18-001373

4//SEC Filing

Raved Ari 4

Accession 0001178913-18-001373

CIK 0001641631other

View on SEC.gov Company Profile

Filed

Apr 29, 8:00 PM ET

Accepted

Apr 30, 5:43 PM ET

Size

10.9 KB

Accession

0001178913-18-001373

Insider Transaction Report

Form 4

Period: 2018-02-16

AIT Therapeutics, Inc.AITB

Director

Transactions

Purchase
Tranche A Warrant (right to buy)
2018-02-16$0.01/sh+11,709$117→ 11,709 total
Exercise: $4.25From: 2018-02-16Exp: 2018-02-19→ Common Stock (11,709 underlying)
Purchase
Tranche B Warrant (right to buy)
2018-02-16$0.01/sh+11,709$117→ 11,709 total
Exercise: $4.25From: 2018-02-16Exp: 2021-02-15→ Common Stock (11,709 underlying)
Exercise/Conversion
Common Stock
2018-02-16$4.25/sh+11,709$49,763→ 639,885 total
Exercise/Conversion
Tranche A Warrant (right to buy)
2018-02-16−11,709→ 0 total
Exercise: $4.25From: 2018-02-16Exp: 2018-02-19→ Common Stock (11,709 underlying)

Documents

1 file

4
zk1821567.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

AIT Therapeutics, Inc.

CIK 0001641631

Entity typeother

Related Parties

1

filerCIK 0001704289

Filing Metadata

Form type: 4
Filed: Apr 29, 8:00 PM ET
Accepted: Apr 30, 5:43 PM ET
Size: 10.9 KB

View on SEC.gov